| Lixisenatide in patients with type 2 diabetes and acute coronary syndrome MA Pfeffer, B Claggett, R Diaz, K Dickstein, HC Gerstein, LV Křber, ... New England Journal of Medicine 373 (23), 2247-2257, 2015 | 2637 | 2015 |
| 2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology … AR Lyon, T Lopez-Fernandez, LS Couch, R Asteggiano, MC Aznar, ... European Heart Journal-Cardiovascular Imaging 23 (10), e333-e465, 2022 | 1766 | 2022 |
| Early versus delayed, provisional eptifibatide in acute coronary syndromes RP Giugliano, JA White, C Bode, PW Armstrong, G Montalescot, BS Lewis, ... New England Journal of Medicine 360 (21), 2176-2190, 2009 | 590 | 2009 |
| Rationale, design, and baseline characteristics in Evaluation of LIXisenatide in Acute Coronary Syndrome, a long-term cardiovascular end point trial of lixisenatide versus placebo R Bentley-Lewis, D Aguilar, MC Riddle, B Claggett, R Diaz, K Dickstein, ... American heart journal 169 (5), 631-638. e7, 2015 | 122 | 2015 |
| Angiographic and clinical outcomes among patients with acute coronary syndromes presenting with isolated anterior ST-segment depression: a TRITON–TIMI 38 (trial to assess … YB Pride, P Tung, S Mohanavelu, C Zorkun, SD Wiviott, EM Antman, ... JACC: Cardiovascular Interventions 3 (8), 806-811, 2010 | 105 | 2010 |
| Use of the TIMI frame count in the assessment of coronary artery blood flow and microvascular function over the past 15 years V Kunadian, C Harrigan, C Zorkun, AM Palmer, KJ Ogando, LH Biller, ... Journal of thrombosis and thrombolysis 27, 316-328, 2009 | 64 | 2009 |
| Effect of prasugrel versus clopidogrel on outcomes among patients with acute coronary syndrome undergoing percutaneous coronary intervention without stent implantation: A TRial … YB Pride, SD Wiviott, JL Buros, C Zorkun, MU Tariq, EM Antman, ... American heart journal 158 (3), e21-e26, 2009 | 58 | 2009 |
| Angiographic outcomes in the PLATO trial (Platelet Inhibition and Patient Outcomes) V Kunadian, SK James, DM Wojdyla, C Zorkun, J Wu, RF Storey, PG Steg, ... JACC: Cardiovascular Interventions 6 (7), 671-683, 2013 | 53 | 2013 |
| Left ventricular dysfunction in the setting of takotsubo cardiomyopathy: a review of clinical patterns and practical implications K Yalta, M Yilmaztepe, C Zorkun Cardiac failure review 4 (1), 14, 2018 | 51 | 2018 |
| Late versus early myocardial remodeling after acute myocardial infarction: a comparative review on mechanistic insights and clinical implications K Yalta, MB Yilmaz, T Yalta, O Palabiyik, G Taylan, C Zorkun Journal of cardiovascular pharmacology and therapeutics 25 (1), 15-26, 2020 | 49 | 2020 |
| Facilitated percutaneous coronary intervention in patients with acute myocardial infarction transferred from remote hospitals D Dudek, K Żmudka, GL Kałuża, M Kuta, P Pieniążek, T Przewłocki, ... American Journal of Cardiology 91 (2), 227-229, 2003 | 37 | 2003 |
| Association of non-steroidal anti-inflammatory drugs with outcomes in patients with ST-segment elevation myocardial infarction treated with fibrinolytic therapy: an ExTRACT … C Michael Gibson, YB Pride, PE Aylward, JJ Col, SG Goodman, D Gulba, ... Journal of thrombosis and thrombolysis 27, 11-17, 2009 | 35 | 2009 |
| Intracoronary pharmacotherapy in the management of coronary microvascular dysfunction V Kunadian, C Zorkun, SP Williams, LH Biller, AM Palmer, KJ Ogando, ... Journal of thrombosis and thrombolysis 26, 234-242, 2008 | 35 | 2008 |
| Determinants of coronary collateral circulation in patients with coronary artery disease C Zorkun, E Akkaya, A Zorlu, İ Tandoğan Anatolian Journal of Cardiology 13 (2), 2013 | 33 | 2013 |
| Association between angiographic complications and clinical outcomes among patients with acute coronary syndrome undergoing percutaneous coronary intervention: an EARLY ACS … YB Pride, S Mohanavelu, C Zorkun, V Kunadian, RP Giugliano, LK Newby, ... JACC: Cardiovascular Interventions 5 (9), 927-935, 2012 | 25 | 2012 |
| Intracoronary administration of abciximab in ST-elevation myocardial infarction CM Gibson, C Zorkun, V Kunadian Circulation 118 (1), 6-8, 2008 | 25 | 2008 |
| Hyperglycaemia, ejection fraction and the risk of heart failure or cardiovascular death in patients with type 2 diabetes and a recent acute coronary syndrome SH Shin, B Claggett, MA Pfeffer, H Skali, J Liu, D Aguilar, R Diaz, ... European Journal of Heart Failure 22 (7), 1133-1143, 2020 | 20 | 2020 |
| Patient characteristics and statin discontinuation-related factors during treatment of hypercholesterolemia: an observational non-interventional study in patients with statin … L Tokgözoğlu, R Özdemir, R Altındağ, C Ceyhan, E Yeter, C Öztürk, ... Türk Kardiyoloji Derneği Arşivi 44 (1), 2016 | 19 | 2016 |
| Takotsubo cardiomyopathy and acute coronary syndromes: Are they always mutually exclusive? K Yalta, F Ucar, M Yilmaztepe, C Zorkun Indian Heart Journal 70 (2), 326, 2018 | 15 | 2018 |
| Angiographic outcomes with early eptifibatide therapy in non–ST-segment elevation acute coronary syndrome (from the EARLY ACS Trial) V Kunadian, RP Giugliano, LK Newby, C Zorkun, J Guo, A Bagai, ... The American Journal of Cardiology 113 (8), 1297-1305, 2014 | 15 | 2014 |
C. Michael Gibson, M.D.Harvard Medical SchoolVerified email at bidmc.harvard.edu
